These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17444410)

  • 1. Interpretive criteria for mupirocin susceptibility testing of Staphylococcus spp. using CLSI guidelines.
    Creagh S; Lucey B
    Br J Biomed Sci; 2007; 64(1):1-5. PubMed ID: 17444410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretive criteria to differentiate low- and high-level mupirocin resistance in Staphylococcus aureus.
    Moreira de Oliveira NE; Cardozo APCM; Marques EA; Netto Dos Santos KR; deMarval MG
    J Med Microbiol; 2007 Jul; 56(Pt 7):937-939. PubMed ID: 17577059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretive criteria for testing susceptibility of staphylococci to mupirocin.
    Finlay JE; Miller LA; Poupard JA
    Antimicrob Agents Chemother; 1997 May; 41(5):1137-9. PubMed ID: 9145883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods.
    Deshpande LM; Fix AM; Pfaller MA; Jones RN;
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):283-90. PubMed ID: 12007448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin.
    Palepou MF; Johnson AP; Cookson BD; Beattie H; Charlett A; Woodford N
    J Antimicrob Chemother; 1998 Nov; 42(5):577-83. PubMed ID: 9848440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus.
    Swenson JM; Wong B; Simor AE; Thomson RB; Ferraro MJ; Hardy DJ; Hindler J; Jorgensen J; Reller LB; Traczewski M; McDougal LK; Patel JB
    J Clin Microbiol; 2010 Jul; 48(7):2469-75. PubMed ID: 20444971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program.
    Gales AC; Andrade SS; Sader HS; Jones RN
    J Chemother; 2004 Aug; 16(4):323-8. PubMed ID: 15332704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus.
    Malaviolle X; Nonhoff C; Denis O; Rottiers S; Struelens MJ
    J Antimicrob Chemother; 2008 Nov; 62(5):1018-23. PubMed ID: 18765413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mupirocin resistance in Staphylococcus aureus in an Indian hospital.
    Gadepalli R; Dhawan B; Mohanty S; Kapil A; Das BK; Chaudhry R; Samantaray JC
    Diagn Microbiol Infect Dis; 2007 May; 58(1):125-7. PubMed ID: 17240103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of mupirocin E-test for susceptibility testing of Staphylococcus aureus.
    Mondino PJJ; Netto Dos Santos KR; do Carmo de Freire Bastos M; Giambiagi-deMarval M
    J Med Microbiol; 2003 May; 52(Pt 5):385-387. PubMed ID: 12721313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA.
    Desroches M; Potier J; Laurent F; Bourrel AS; Doucet-Populaire F; Decousser JW;
    J Antimicrob Chemother; 2013 Aug; 68(8):1714-7. PubMed ID: 23535880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
    Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
    Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
    Abb J
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):319-21. PubMed ID: 12151194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mupirocin resistance in clinical isolates of staphylococci in a tertiary care centre in south India.
    Oommen SK; Appalaraju B; Jinsha K
    Indian J Med Microbiol; 2010; 28(4):372-5. PubMed ID: 20966573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
    Simor AE; Stuart TL; Louie L; Watt C; Ofner-Agostini M; Gravel D; Mulvey M; Loeb M; McGeer A; Bryce E; Matlow A;
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3880-6. PubMed ID: 17724154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci.
    Zhang K; Sparling J; Chow BL; Elsayed S; Hussain Z; Church DL; Gregson DB; Louie T; Conly JM
    J Clin Microbiol; 2004 Nov; 42(11):4947-55. PubMed ID: 15528678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals.
    Petinaki E; Spiliopoulou I; Kontos F; Maniati M; Bersos Z; Stakias N; Malamou-Lada H; Koutsia-Carouzou Ch; Maniatis AN
    J Antimicrob Chemother; 2004 Jan; 53(1):105-8. PubMed ID: 14657085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.
    Schmitz FJ; Lindenlauf E; Hofmann B; Fluit AC; Verhoef J; Heinz HP; Jones ME
    J Antimicrob Chemother; 1998 Oct; 42(4):489-95. PubMed ID: 9818748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.